Endocrinol Metab Clinics North America (2020) 49:34755
Toxicol Appl Pharmacol 107: 215227
Expert Recommendations and Guidelines Medical providers can help assess individual health needs and potential risks to the infant
Its phase 2 data demonstrated substantial weight loss, and topline phase 3 results suggest the possibility of weight reduction approaching or exceeding that of earlier incretin-based pharmacotherapies
Bai X, Lei M, Shi J, Yu Y, Qiu W, Lai X, Liu Y, Yang T, Yang L, Widelitz RB, Chuong C-M, Lian X (2015) Roles of gasdermina3 in catagentelogen transition during hair cycling
The peptide's unique dual receptor mechanism, targeting both amylin (AMY1R, AMY2R, AMY3R) and calcitonin receptors (CTR), provides a novel approach to appetite regulation and metabolic control that goes beyond traditional GLP-1 therapies